With reference to their earlier disclosures related to setup of Active Pharmaceutical Ingredient (API) /Intermediate manufacturing plant of Isometamidium (Isometa), Evexia Lifecare Limited announced that the company has completed all the formalities in respect of Government Licenses. Now, the company has planned to start its manufacturing facility from 18th April 2022 onwards at Vadodara based plant. The company has also decided to build up more than 150,000 sqft plant facility at Vadodara based location.

This facility will be in accordance with the USFDA for the manufacturing of the other APIs and Intermediate products.